U.S. Markets open in 7 hrs 5 mins
S&P Futures
3,808.25-8.50(-0.22%)Dow Futures
31,204.00-32.00(-0.10%)Nasdaq Futures
12,641.25-40.50(-0.32%)
Certara, Inc. (CERT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.91-1.58 (-4.45%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 35.49 |
| Open | 35.32 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 900 |
| Day's Range | 33.87 - 36.03 |
| 52 Week Range | 29.70 - 41.79 |
| Volume | 286,972 |
| Avg. Volume | 986,874 |
| Market Cap | 5.188B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36.80 |
- Business Wire
Certara to Present at the Barclays Global Healthcare Conference
Certara today announced that William Feehery, CEO and Andrew Schemick, CFO will virtually present at the Barclays Global Healthcare Conference.
- Business Wire
The Year 2020 Marks the 7th Consecutive Year Certara Customers Received 90 Percent of US FDA Novel Drug and Biologic Approvals
2020 was the 7th consecutive year where 90% of new drug & biologic approvals by the FDA were received by Certara’s customers.
- Business Wire
Certara to Report Fourth Quarter and Full Year 2020 Preliminary Financial Results on March 4, 2021
Certara will release preliminary financial results for the fourth quarter and full year of 2020 after the market close on Thursday, March 4, 2021.
© 2021 Verizon Media. All rights reserved.
